Global Contraceptive Devices Market 2015-2019

避妊具の世界市場2015-2019

◆タイトル:Global Contraceptive Devices Market 2015-2019
◆商品コード:IRTNTR6472
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年7月15日
◆ページ数:91
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、避妊具の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、避妊具の世界市場規模及び予測、製品別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Contraception Devices
Contraception methods can be temporary or permanent and are available for both men and women. Permanent methods include sterilization for women (tubal occlusion or hysteroscopy) and sterilization for men (vasectomy). Temporary methods are hormonal and non-hormonal. Hormonal methods include contraceptive transdermal patches, oral contraceptive pills, hormonal IUDs, vaginal rings, and vaginal implants. Non-hormonal methods include withdrawal methods, diaphragms, condoms, sponges, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges, and cervical caps are also referred to as barrier contraception methods.

Technavio’s analysts forecast the global contraceptive devices market to grow at a CAGR of 4.88% over the period 2014-2019.

[Covered in this Report]
The report includes the present scenario and the growth prospects of the global contraceptive devices market for the period 2015-2019. To calculate the market size, we considered revenue generated from sales of various contraception devices.

Technavio’s report, Global Contraceptive Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global contraceptive devices market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• EMEA
• APAC

[Key Vendors]
• Ansell
• Actavis
• Bayer
• Church & Dwight
• Merck & Co

[Other Prominent Vendor]
• Agile Therapeutics
• Caya
• Condomi Health International
• Fuji Latex
• HLL Lifecare
• Karex Industries
• Lipocine
• Mayer Laboratories
• Medicines 360
• Okamoto Industries
• Reckitt Benckiser Group
• Teva Pharmaceuticals
• The Female Health Company
• TodaySponge

[Market Driver]
• Growing Prevalence of Unplanned Pregnancies
• For a full, detailed list, view our report

[Market Challenge]
• Threat of Low-Cost Generic Contraceptives
• For a full, detailed list, view our report

[Market Trend]
• Increasing Strategic Partnerships
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Types of Contraceptive Methods

07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis

08.Market Segmentation by Product Type

09.Global Condoms Market
09.1 Market Size and Forecast

10.Global IUDs Market
10.1 Market Size and Forecast

11.Global Subdermal Contraceptive Implants Market
11.1 Market Size and Forecast

12.Global Vaginal Rings Market
12.1 Market Size and Forecast

13.Global Non-surgical Permanent Contraception Devices Market
13.1 Market Size and Forecast

14.Global Contraceptive Diaphragms Market
14.1 Market Size and Forecast

15.Global Contraceptive Sponges Market
15.1 Market Size and Forecast

16.Geographical Segmentation
16.1 Contraceptive Devices Market in Americas
16.1.1 Market Size and Forecast
16.2 Contraceptive Devices Market in EMEA
16.2.1 Market Size and Forecast
16.3 Contraceptive Devices Market in APAC
16.3.1 Market Size and Forecast

17.Buying Criteria

18.Market Growth Drivers

19.Drivers and Their Impact

20.Market Challenges

21.Impact of Drivers and Challenges

22.Market Trends

23.Trends and Their Impact

24.Vendor Landscape
24.1 Competitive Scenario
24.1.1 Key News
24.1.2 Mergers and Acquisitions
24.2 Market Share Analysis 2014
24.2.1 Actavis
24.2.2 Ansell
24.2.3 Bayer
24.2.4 Church & Dwight
24.2.5 Merck
24.3 Other Prominent Vendors

25.Key Vendor Analysis
25.1 Actavis
25.1.1 Key Facts
25.1.2 Business Overview
25.1.3 Business Segmentation
25.1.4 Business Segmentation by Revenue 2012 and 2013
25.1.5 Geographical Segmentation by Sales 2013
25.1.6 Business Strategy
25.1.7 Recent Developments
25.1.8 SWOT Analysis
25.2 Ansell
25.2.1 Key Facts
25.2.2 Business Overview
25.2.3 Business Segmentation by Revenue 2014
25.2.4 Business Segmentation by Revenue 2013 and 2014
25.2.5 Geographical Segmentation by Revenue 2014
25.2.6 Recent Developments
25.2.7 SWOT Analysis
25.3 Bayer
25.3.1 Key Facts
25.3.2 Business Overview
25.3.3 Business Segmentation by Revenue 2014
25.3.4 Business Segmentation by Revenue 2013 and 2014
25.3.5 Geographical Segmentation by Revenue 2014
25.3.6 Business Strategy
25.3.7 Recent Developments
25.3.8 SWOT Analysis
25.4 Church & Dwight
25.4.1 Key Facts
25.4.2 Business Overview
25.4.3 Business Segmentation by Revenue 2013
25.4.4 Business Segmentation by Revenue 2012 and 2013
25.4.5 Geographical Segmentation by Revenue 2013
25.4.6 Business Strategy
25.4.7 Recent Developments
25.4.8 SWOT Analysis
25.5 Merck
25.5.1 Key Facts
25.5.2 Business Overview
25.5.3 Business Segmentation by Revenue 2013
25.5.4 Business Segmentation by Revenue 2012 and 2013
25.5.5 Sales by Geography
25.5.6 Business Strategy
25.5.7 Key Developments
25.5.8 SWOT Analysis

26.Other Reports in This Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Market Overview
Exhibit 3: Global Contraceptive Devices Market 2014-2019 ($ millions)
Exhibit 4: Segmentation of Global Contraceptive Devices Market by Product Type
Exhibit 5: Segmentation of Global Contraceptive Devices Market by Product Type 2014
Exhibit 6: Global Condoms Market 2014-2019 ($ millions)
Exhibit 7: Global IUDs Market 2014-2019 ($ millions)
Exhibit 8: Global Subdermal Contraceptive Implants Market 2014-2019 ($ millions)
Exhibit 9: Global Vaginal Rings Market 2014-2019 ($ millions)
Exhibit 10: Global Non-surgical Permanent Contraception Devices Market 2014-2019 ($ millions)
Exhibit 11: Global Contraceptive Diaphragms Market 2014-2019 ($ millions)
Exhibit 12: Global Contraceptive Sponges Market 2014-2019 ($ millions)
Exhibit 13: Segmentation of Global Contraceptive Devices Market by Product Type 2014-2019 ($ millions)
Exhibit 14: Segmentation of Global Contraceptive Devices Market by Product Type 2014-2019
Exhibit 15: Segmentation of Global Contraceptive Devices Market by Geography 2014
Exhibit 16: Contraceptive Devices Market in Americas 2014-2019 ($ millions)
Exhibit 17: Contraceptive Devices Market in EMEA 2014-2019 ($ millions)
Exhibit 18: Contraceptive Devices Market in APAC 2014-2019 ($ millions)
Exhibit 19: Segmentation of Global Contraceptive Devices Market by Geography 2014-2019 ($ millions)
Exhibit 20: Segmentation of Global Contraceptive Devices Market by Geography 2014-2019
Exhibit 21: Major Drivers of Global Contraceptive Devices Market
Exhibit 22: STDs in US
Exhibit 23: Estimated Cases of STIs in US
Exhibit 24: Total Population Growth Rate and Crude Birthrate 2007-2012
Exhibit 25: Major Challenges in Global Contraceptive Devices Market
Exhibit 26: Major Trends in Global Contraceptive Devices Market
Exhibit 27: Global Fertility Rate 2007-2012
Exhibit 28: Actavis: Key Takeaways
Exhibit 29: Ansell: Key Takeaways
Exhibit 30: Bayer: Key Takeaways
Exhibit 31: Church & Dwight: Key Takeaways
Exhibit 32: Merck: Key Takeaways
Exhibit 33: Actavis: Business Segmentation
Exhibit 34: Actavis: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 35: Actavis: Geographical Segmentation by Sales 2013
Exhibit 36: Ansell: Business Segmentation by Revenue 2014
Exhibit 37: Ansell: Business Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 38: Ansell: Geographical Segmentation by Revenue 2014
Exhibit 39: Bayer: Business Segmentation by Revenue 2014
Exhibit 40: Bayer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 41: Bayer: Geographical Segmentation by Revenue 2014
Exhibit 42: Church & Dwight: Business Segmentation by Revenue 2013
Exhibit 43: Church & Dwight: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 44: Church & Dwight: Geographical Segmentation by Revenue 2013
Exhibit 45: Merck: Business Segmentation by Revenue 2013
Exhibit 46: Merck: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 47: Merck: Sales by Geography 2013



【掲載企業】

Ansell, Actavis, Bayer, Church & Dwight,Merck & Co, Agile Therapeutics, Caya, Condomi Health International, Fuji Latex, HLL Lifecare, Karex Industries, Lipocine, Mayer Laboratories, Medicines 360, Okamoto Industries, Reckitt Benckiser Group, Teva Pharmaceuticals, The Female Health Company, TodaySponge

【資料のキーワード】

避妊具、不妊、コンドーム、IUD、皮下避妊インプラント、避妊リング、妊娠、男性避妊、女性避妊

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[避妊具の世界市場2015-2019] (Global Contraceptive Devices Market 2015-2019 / IRTNTR6472)販売に関する免責事項
[避妊具の世界市場2015-2019] (Global Contraceptive Devices Market 2015-2019 / IRTNTR6472)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆